[Focus on molecular imaging in prostate cancer].
BACKGROUND
Prostate cancer is the most frequent cancer in men in France and it is a public health issue. This cancer is heterogenous. There is a clinical need of an accurate non-invasive imaging method to improve diagnosis, guide the choice of therapy and evaluate its efficacy. We undertook to critically review the different molecular imaging probes, currently used or in clinical trial.


METHODS
A systematic review of the literature was performed in Pubmed/Medline database by searching for articles in French or English published on PET tracer in prostate cancer in clinical application.


RESULTS
Several PET tracers are under investigation because of the low performance of the FDG in prostate cancer. In France, only two new PET tracers have the marketing authorization: the NaF and choline, but these tracers have several limitations. The NaF analyses only bone metastasis. The choline has changed the recurrence of prostate cancer but is not effective for recurrence with low PSA, furthermore its sensitivity is low for the detection of lymph nodes metastasis in initial disease. Several tracers in trial including the PSMA offer encouraging prospects in initial staging and for recurrences.


CONCLUSIONS
An accurate knowledge in molecular biology allowed to develop the metabolic imagery. Many new tracers are under evaluation in prostate cancer. The indication of each of them needs to be established.
Department of Surgery and Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, États-Unis.
L
L
Michaud
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, États-Unis; Department of Urology, Weill Cornell Medical College, New York, NY, États-Unis. Electronic address: touijerk@mskcc.org.
K A
KA
Touijer
D006801:Humans; D008297:Male; D057054:Molecular Imaging; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging*
Cancer prostatique; Choline; PET/CT; PSMA; Prostate cancer; TEP/TDM
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1766-74
18465129
Ann Nucl Med. 2012 Feb;26(2):138-45
22069194
Eur Urol. 2015 Feb;67(2):299-309
24571959
Radiology. 2014 Mar;270(3):849-56
24475804
Medicine (Baltimore). 2015 Oct;94(41):e1701
26469908
Clin Oncol (R Coll Radiol). 2016 Sep;28(9):550-67
27256655
Nucl Med Commun. 2013 Oct;34(10 ):935-45
23903557
Curr Urol Rep. 2016 Mar;17 (3):18
26874530
J Nucl Med. 2007 Jan;48(1):56-63
17204699
Eur Urol. 2015 Sep;68(3):530-4
25957851
Radiology. 2010 Mar;254(3):925-33
20177103
Prostate. 2014 Feb;74(2):217-24
24150752
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1784-93
26194716
Eur Urol. 2016 Mar;69(3):393-6
26116958
Theranostics. 2014 Feb 01;4(4):412-9
24578724
Acta Radiol. 2016 Apr;57(4):487-93
25907118
Am J Nucl Med Mol Imaging. 2012;2(1):33-47
23133801
J Nucl Med. 2010 Feb;51(2):183-92
20080885
Nucl Med Commun. 2014 Mar;35(3):221-30
24240194
J Nucl Med. 2014 Feb;55(2):233-41
24408897
Clin Nucl Med. 2013 May;38(5):305-14
23486334
J Urol. 2005 Jan;173(1):66-9; discussion 69
15592030
Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97
24352789
Eur Urol. 2013 Jun;63(6):1040-8
23036576
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S36-40
23579864
Nucl Med Biol. 2015 Apr;42(4):340-8
25618796
Radiology. 2007 Sep;244(3):797-806
17652190
Eur Urol. 2013 Jul;64(1):106-17
23628493
Clin Nucl Med. 2015 Aug;40(8):e386-91
26053708
J Urol. 2016 May;195(5):1436-43
26682756
J Nucl Med. 2006 Feb;47(2):287-97
16455635
BJU Int. 2013 Dec;112(8):1062-72
23937453
J Nucl Med. 2012 Apr;53(4):538-45
22343504
Urology. 1998 Oct;52(4):637-40
9763084
Clin Cancer Res. 2013 Oct 1;19(19):5434-43
23935037
Radiology. 2014 Apr;271(1):220-9
24475817
J Nucl Med. 2015 May;56(5):668-74
25791990
Clin Radiol. 2008 Apr;63(4):387-95
18325358
Clin Chem Lab Med. 2014 May;52(5):725-33
24310773
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209
25411132
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12 ):2114-2121
27290607
J Nucl Med. 2015 Aug;56(8):1185-90
26112024
Tomography. 2015 Sep;1(1):18-22
26726317
Clin Cancer Res. 2010 Dec 15;16(24):6093-9
20975102
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
24072344
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):55-69
26450693
Mol Imaging Biol. 2010 Jan-Feb;12 (1):98-107
19588206
J Nucl Med. 2004 Mar;45(3):366-73
15001675
Eur Urol. 2016 Nov;70(5):829-836
26795686
Radiographics. 2016 Jan-Feb;36(1):142-59
26587888